Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-20
2007-02-20
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S155000
Reexamination Certificate
active
10964489
ABSTRACT:
This invention describes compounds of Formula (I) which are modulators of potassium channels and are useful for treating conditions affected by abnormal potassium channel activity including erectile dysfunction and irritable bowel syndrome
REFERENCES:
patent: 5892045 (1999-04-01), Sit et al.
patent: 5922735 (1999-07-01), Sit et al.
patent: 5972961 (1999-10-01), Hewawasam et al.
patent: 6184231 (2001-02-01), Hewawasam et al.
patent: 6353119 (2002-03-01), Crispino et al.
patent: 6538022 (2003-03-01), Pollesello et al.
patent: 7049309 (2006-05-01), Boy et al.
patent: 2002371078 (2002-12-01), None
patent: WO 02/26713 (2002-04-01), None
P. Hewawasam, et al, “4-Aryl-3-(Hydroxyalkyl)Quinolin-2-Ones: Novel Maxi-K Channel Opening Relaxants of Corporal Smooth Muscle Targeted for Erectile Dysfunction,” J. Med. Chem., 46, pp. 2819-2822, 2003.
Boy Kenneth M.
Hewawasam Piyasena
Sit Sing-Yuen
Bristol--Myers Squibb Company
Epperson James
Makujina Shah
Seaman D. Margaret
LandOfFree
3-thia-4-arylquinolin-2-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-thia-4-arylquinolin-2-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-thia-4-arylquinolin-2-one derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3829925